Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02608684
Title A Study of Pembrolizumab With Standard Treatment in Patients With Recurrent Platinum-resistant Ovarian Cancer
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Cedars-Sinai Medical Center
Indications

fallopian tube carcinoma

ovarian carcinoma

peritoneal carcinoma

Therapies

Cisplatin + Gemcitabine + Pembrolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.